Order results by:
Issue | Title | |
Vol 14, No 3 (2022) | The impact of non-motor disorders on the quality of life of patients with cervical muscular dystonia | Abstract similar documents |
M. R. Nodel, N. I. Salouhina, V. A. Tolmacheva | ||
"... correlation was established between the total assessment of QoL and the severity of dystonia (r=0.35; p<0.01 ..." | ||
Vol 10, No 3 (2018) | Non-motor disorders in cervical dystonia | Abstract similar documents |
V. A. Tolmacheva, M. R. Nodel, N. I. Saloukhna | ||
"... of dystonia. It is important to identify possible cognitive and mental disorders, sleep and perceptual ..." | ||
Vol 11, No 3 (2019) | A case of segmental dystonia with mental/psychic nonmotor disorders | Abstract similar documents |
V. A. Tolmacheva, D. V. Romanov, D. A. Grishina | ||
"... dystonia, the presence of cognitive and mental disorders in dystonia. It presents a clinical case of severe ..." | ||
Vol 11, No 4 (2019) | Cognitive impairment and mental disorders in patients with focal muscular dystonia | Abstract similar documents |
V. A. Tolmacheva, D. A. Grishina, D. V. Romanov | ||
"... Non-motor manifestations in focal muscular dystonia (FMD) have been little studied. Objective ..." | ||
Vol 14, No 4 (2022) | Anxiety-depressive spectrum disorders in cervical dystonia | Abstract similar documents |
V. A. Tolmacheva, P. G. Yuzbashyan, D. S. Petelin, B. A. Volel, N. I. Salouhina, M. R. Nodel, D. V. Romanov | ||
"... A decrease in the quality of life (QoL) in cervical dystonia (CD) is often due to anxiety ..." | ||
Vol 12, No 3 (2020) | Cervical dystonia: non-motor aspects | Abstract similar documents |
O. A. Druzhinina, N. G. Zhukova, L. P. Shperling, D. A. Novotnyi | ||
"... Cervical dystonia (CD) is manifested by violent, often painful movements of the neck muscles ..." | ||
Vol 10, No 1 (2018) | Cranial dystonia | Abstract similar documents |
V. A. Tolmacheva | ||
"... Cranial dystonia is a common disease of the extrapyramidal nervous system. The clinical ..." | ||
Vol 12, No 5 (2020) | Drug-induced dystonia | Abstract PDF (Eng) similar documents |
T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
"... Drug-induced dystonia (DID) is a rarely diagnosed adverse reaction to a sufficiently large number ..." | ||
Vol 9, No 4 (2017) | The course of cervical dystonia with head tremor during botulinum toxin type A treatment | Abstract similar documents |
A. N. Korenko, A. A. Skoromets, A. A. Timofeeva, A. V. Tishkov | ||
"... dystonia (CD) within the first 8 cycles of treatment. Patients and methods. The investigation included 76 ..." | ||
Vol 13, No 4 (2021) | Rehabilitation approaches in cervical dystonia | Abstract similar documents |
Z. A. Zalyalova, E. R. Iusupova | ||
"... Cervical dystonia (CD) is a form of focal muscular dystonia. The pathophysiology of CD includes ..." | ||
Vol 8, No 2 (2016) | Psychogenic dystonia of the hand: A clinical case | Abstract similar documents |
A. I. Baidauletova, O. A. Shavlovskaya | ||
"... The article describes a clinical case of psychogenic movement disorder appearing as fixed dystonia ..." | ||
Online-first | Когнитивные и психические нарушения у пациентов с фокальной мышечной дистонией | Abstract similar documents |
В. A. Толмачева, Д. А. Гришина, Д. В. Романов | ||
"... При фокальной мышечной дистонии (ФМД) мало изучены недвигательные проявления. Цель исследования ..." | ||
Vol 12, No 5 (2020) | Cervical dystonia: current rehabilitation strategies and methods | Abstract similar documents |
A. S. Istomina, I. V. Miliukhina, M. D. Didur | ||
"... Idiopathic cervical dystonia (CD) is a movement disorder that is characterized by sustained ..." | ||
Vol 15, No 5 (2023) | Comprehensive diagnosis of cervical dystonia and the efficacy of long-term (three-year) botulinum therapy | Abstract similar documents |
V. A. Tolmacheva, D. S. Petelin, B. A. Volel | ||
"... Cervical dystonia (CD) is common in outpatient practice but in many cases is diagnosed at late ..." | ||
Vol 14, No 1 (2022) | Functional writer's cramp as psychogenic focal dystonia | Abstract PDF (Eng) similar documents |
V. A. Tolmacheva, P. G. Yuzbashyan, R. M. Shishorin, B. A. Volel, D. V. Romanov | ||
"... and tension in the right hand when writing; thus, we suspected kinesigenic dystonia in the form of writer ..." | ||
Vol 14, No 6 (2022) | Mental disorders in cervical dystonia – clinical heterogeneity, impact on disease severity and quality of life | Abstract similar documents |
A. A. Ragimova, D. S. Petelin, T. Y. Avseytseva, M. A. Samushia, A. F. Ivolgin | ||
"... diagnosis of cervical dystonia (CD), as well as their impact on the severity of a neurological disease ..." | ||
Vol 13, No 6 (2021) | Novel approaches to the treatment of cervical dystonia. The concept of dual navigation control | Abstract PDF (Eng) similar documents |
A. P. Kovalenko, Z. A. Zalyalova, A. F. Ivolgin | ||
"... Сervical dystonia (CD) is the most common type of focal dystonia (up to 50% of all dystonia cases ..." | ||
Vol 8, No 2 (2016) | Possibilities of using computed tomography to treat mixed cervical dystonia with botulinum toxin type A | Abstract similar documents |
T. V. Mokina, Yu. I. Pavlov, Z. A. Zalyalova | ||
"... dystonia (CD). The poor result of initial treatment is due to the fact that the abnormally active deep ..." | ||
Vol 13, No 1 (2021) | Benign essential blepharospasm: epidemiology, clinical manifestations, pathophysiology, botulinum toxin therapy | Abstract similar documents |
Z. A. Zalyalova | ||
"... Blepharospasm (BPS) is a variant of focal dystonia manifested by involuntary eyelid spasms with eye ..." | ||
Vol 8, No 3 (2016) | A clinical case of adult onset Niemann–Pick disease type C | Abstract similar documents |
E. V. Saifullina, R. V. Magzhanov, A. K. Mardanova, T. Yu. Proshlyakova, E. Yu. Zakharova, S. A. Klyushnikov, S. N. Illarioshkin | ||
Vol 3, No 1 (2011) | Sleep disorders in Parkinson's disease | Abstract similar documents |
M. R. Nodel | ||
"... in the severity of motor (hypokinesis, rigidity, tremor, nocturnal and morning dystonia) and nonmotor (restless ..." | ||
Vol 8, No 2 (2016) | Ultrasound-guided botulinum toxin injections | Abstract similar documents |
S. E. Khatkova, A. A. Balbert | ||
"... for muscular dystonia, spasticity, and other diseases accompanied by spasm, pain, and autonomic dysfunction ..." | ||
Vol 15, No 2 (2023) | Quality of life of patients with rheumatoid arthritis and comorbid fibromyalgia | Abstract similar documents |
N. A. Melikova, E. S. Filatova, E. G. Filatova, A. M. Lila | ||
"... .003), anxiety (p=0.001), sleep quality (p<0.001) and cognitive impairment (p=0.021). The QoL of patients ..." | ||
Vol 9, No 1 (2017) | Some risk factors of stroke in dwellers of the Republic of Tyva | Abstract similar documents |
B. M. Doronin, Kh. D. Mongush | ||
"... cerebrovascular accident, or vegetative vascular dystonia. Results. The survey showed that 17 ..." | ||
Vol 15, No 3 (2023) | Managing patients with positional vertigo: diagnostic pitfalls and treatment | Abstract similar documents |
S. Yu. Lavrik, A. S. Borisov, V. V. Shprakh, I. M. Mikhalevich | ||
"... artery syndrome, and vegetative-vascular dystonia. However, none of these diagnoses was confirmed ..." | ||
Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
"... with PD. Objective: to analyze neuropsychological status and quality of life (QOL) in PD patients ..." | ||
Vol 6, No 2 (2014) | A clinical case of SYNGAP1, с2214_2217delTGAG de novo gene mutations in a girl with epilepsy, mental retardation, autism, and movement disorders | Abstract similar documents |
M.Yu Bobylova, M.B. Mironov, A.V. Kulikov, M.V Kazakova, M.A. Bogacheva, Yu.A. Tankevich, L.Yu. Glukhova, E.I Barletova, M.O. Abramov, K.Yu. Mukhin, G.E. Rudenskaya | ||
Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
N. V. Zarubina, N. N. Spirin | ||
"... of depression on the quality of life (QoL) of MS patients has been little studied. Objective: to study ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis | Abstract similar documents |
Ya. V. Vlasov, N. G. Polyarnaya, A. N. Boyko | ||
"... in quality of life (QoL) indexes in patients with PPMS and SPMS. Patients and methods. In total, 437 ..." | ||
Vol 7, No 1 (2015) | Diagnosis and treatment of dizziness in outpatient practice | Abstract similar documents |
L. M. Antonenko, N. V. Bestuzheva, V. A. Parfenov | ||
"... (30%), cervical osteochondrosis (12%), and vegetative dystonia (7%). Results and discussion ..." | ||
Vol 11, No 3 (2019) | Functional (psychosomatic) disorders in general medical practice | Abstract similar documents |
L. V. Romasenko, V. M. Makhov, N. V. Chichkova | ||
"... the clinical picture of diseases: neurocirculatory dystonia (NCD), irritable bowel syndrome (IBS), functional ..." | ||
Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Surgical and medical treatments for discogenic low back radiculopathy | Abstract similar documents |
M. A. Ivanova, V. A. Parfenov, A. O. Isaikin | ||
"... scale (NPRS), Oswestry disability index, and quality of life questionnaire (QOL), SF-12] survey ..." | ||
Vol 14, No 1 (2022) | Effect of vitamin D and other indicators of phosphorus-calcium metabolism on cognitive functions and quality of life in patients with Parkinson's disease | Abstract similar documents |
D. A. Novotnyy, N. G. Zhukova, L. P. Shperling, V. A. Stolyarova, I. A. Zhukova, A. E. Agasheva, S. V. Shtaimets, O. A. Druzhinina, I. V. Shirokikh | ||
"... effect of the level of inorganic phosphorus (β=5.932; p=0.001) and AP (β=0.055; p=0.025) on the QoL ..." | ||
Vol 9, No 4 (2017) | Sleep disorders in Parkinson’s disease: approaches to treatment and prevention | Abstract similar documents |
M. R. Nodel, G. V. Kovrov | ||
"... Нарушения ночного сна являются одними из наиболее значимых недвигательных проявлений болезни ..." | ||
Vol 10, No 3 (2018) | Conservative treatment for patients with discogenic lumbosacral radiculopathy: results of a prospective follow-up | Abstract similar documents |
M. A. Ivanova, V. A. Parfenov, A. I. Isaikin | ||
"... ) of Quality of Life (QoL) Questionnaire on admission to the clinic, at 7-14 days after treatment (pain ..." | ||
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
"... cord (presence of new or active lesions). Previously, there were no studies of quality of life (QoL ..." | ||
Vol 4, No 2 (2012) | Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease | Abstract similar documents |
S N Illarioshkin | ||
"... прамипексола, его влияние на двигательные (в том числе тремор) и недвигательные (депрессия) проявления БП ..." | ||
Vol 13, No 6 (2021) | Cognitive, emotional and motor disorders and their impact on the postoperative rehabilitation of neurosurgical patients | Abstract similar documents |
D. Fantalis, I. S. Preobrazhenskaya | ||
"... in cognitive functions, emotional state, and quality of life (QoL) in the main group 3 and 6 months after ..." | ||
Vol 15, No 6 (2023) | NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational study | Abstract similar documents |
A. B. Danilov, A. A. Pilipovich, M. V. Pyastolova | ||
"... of life (QoL) and daily functioning. Objective: to evaluate the efficacy and safety of the use ..." | ||
Vol 16, No 1 (2024) | A five-point scale for assessing the quality of life of patients with epilepsy | Abstract similar documents |
P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, A. O. Khabibova, A. M. Azhigova, V. A. Kharkovsky | ||
"... The main goal of epilepsy therapy is to improve the patient’s quality of life (QoL), which ..." | ||
Vol 3, No 4 (2011) | Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole | Abstract similar documents |
M. R. Nodel | ||
"... Утомляемость – частый недвигательный симптом болезни Паркинсона (БП), значимо ухудшающий качество ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
"... ) to assess the severity of anxiety and depression and the SF-36 scale to evaluate the quality of life (QoL ..." | ||
Vol 15, No 4 (2023) | Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin | Abstract similar documents |
L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
"... with citicoline (Noocil®) on cognitive function and quality of life (QoL)in patients with mild cognitive ..." | ||
Vol 10, No 4 (2018) | Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease | Abstract similar documents |
M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno | ||
"... Дневная сонливость является одним из клинически значимых недвигательных проявлений болезни ..." | ||
Vol 15, No 4 (2023) | Comorbid disorders and therapy of persistent postural perceptual dizziness | Abstract similar documents |
E. N. Zastenskaya, L. M. Antonenko | ||
"... .80 to 29.6±12.80 points (p<0.001), in the group with PPPD and peripheral vestibular disorders – from 49 ..." | ||
Vol 13, No 5 (2021) | Awareness of cardiovascular diseases risk factors, attitude towards their health and sleep disorders among the 25–64 years old population in Russia/Siberia (WHO International «MONICA-psychosocial» program) | Abstract PDF (Eng) similar documents |
V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelhorn, A. V. Gafarova | ||
"... that they were «not entirely healthy» (men – 65.5%, χ2 =57.825, df=8, p<0.001 and women – 69.6%, χ2 =96.883, df=4 ..." | ||
Vol 15, No 4 (2023) | Psychosocial factors and sleep disorders in the population aged 25–64 years in Russia/Siberia (International WHO MONICA-Psychosocial Programme) | Abstract similar documents |
V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. V. Gafarova | ||
"... of: anxiety (HLA) in 61.8% of men (χ2=56.169; df=4; p<0.001) and 68.1% of women (χ2=36.535; df=4; p<0.001 ..." | ||
Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
"... , USA). Results and discussion. We found a significant (p<0.001) decrease in the thickness ..." | ||
Vol 14, No 4 (2022) | Smoking and sleep disorders (population-based study under the WHO “MONICA-psychosocial” program) | Abstract PDF (Eng) similar documents |
V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelgorn, A. V. Gafarova | ||
"... – 12.2%) and 78.6% of women (satisfactory sleep – 58.9%, poor sleep – 19.7%; χ2 =38.553; df=2; p<0.001 ..." | ||
Vol 16, No 1 (2024) | Evaluation of the therapeutic efficacy of the drug Cytochrome C in the treatment of asthenia in outpatients (CITRIN study) | Abstract similar documents |
V. Yu. Lobzin, A. Yu. Emelin, K. A. Kolmakova | ||
"... , there was a decrease in the severity of asthenia on the MFI-20 scale from 72.2±12.7 to 41.1±12.3 points (p<0.01 ..." | ||
Vol 16, No 1 (2024) | Safety and efficacy of fremanezumab in real clinical practice in patients with chronic migraine | Abstract similar documents |
G. N. Belskaya, A. V. Krasnikov, E. A. Kiryanova, M. E. Prokopovich, E. V. Sakharova, G. V. Makarov | ||
"... by 11.6 per month, with monthly injections – by 12.6 per month (p<0.01). In patients who had negative ..." | ||
Vol 12, No 6 (2020) | Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke | Abstract PDF (Eng) similar documents |
S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, К. V. Sobyanin | ||
"... .7 [30.5; 39.9] ml/m2 vs 28.5 [25.6; 34.6] ml/m2 vs 27.1 [24.5; 31.2] ml/m2 ; p< 0.001) and NT-proBNP ..." | ||
Vol 15, No 6 (2023) | Chronic dizziness: modern treatment methods taking into account comorbidity | Abstract similar documents |
E. N. Zastenskaia, L. M. Antonenko | ||
"... decreased from 45.59±15.47 to 29.9±12.56 points (p<0.001), the severity of anxiety according to BAI from 27 ..." | ||
Vol 16, No 1 (2024) | Cortisol as a cerebral cortex neurons apoptosis regulator in acute phase of ischemic stroke (clinical and pathological study) | Abstract PDF (Eng) similar documents |
S. P. Sergeeva, A. A. Savin, P. F. Litvitsky, L. R. Gorbacheva, A. V. Lyundup, I. D. Breslavich, L. A. Savin | ||
"... of cortisol in peripheral blood in zones 2 (r=0.263; p<0.01) and 3 (r=0.383; p<0.01). In the 2nd zone ..." | ||
Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
"... completely (in 42% of participants) or became subclinical (in 48%; р<0.001). CI severity also reduced ..." | ||
Vol 10, No 4 (2018) | Research Institute of Internal and Preventive Medicine, Branch, Federal Research Center, Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences | Abstract similar documents |
A. V. Titarenko, S. V. Shishkin, L. V. Shcherbakova, E. G. Verevkin, M. Holmes, M. Bobak, S. K. Malyutina | ||
"... groups, which was steeper in women than in men (p<0.001). Persons aged 70 years and older showed negative ..." | ||
Vol 8, No 1 (2016) | Changes in spastic muscles of patients with infantile cerebral palsy according to ultrasound findings | Abstract similar documents |
S. V. Vlasenko, G. M. Kushnir, T. F. Golubeva, E. A. Osmanov, E. V. Strashko | ||
"... ), and age at contracture formation (R=0.60; p=0.001). Analysis of USG and electromyographic findings ..." | ||
Vol 15, No 3 (2023) | Periarticular cysts of the cervical spine | Abstract similar documents |
M. G. Bashlachev, G. Yu. Evzikov | ||
"... .12 points according to VAS (p<0.01), disability according to DI decreased from 51.5±8.08 to 21.25± 4 ..." | ||
Vol 10, No 3 (2018) | Median nerve decompression in carpal tunnel syndrome: short- and long-term results | Abstract similar documents |
A. S. Gilveg, V. A. Parfenov, G. Yu. Evzikov | ||
"... from 2.76 to 1.15 (p≤0.01) and from 2.72 to 1.24 (p≤0.01), respectively; in Group 2, these dropped from ..." | ||
Vol 11, No 1 (2019) | Role of the intact hemisphere in determining the rehabilitation potential in the acute period of ischemic stroke: a diffusion and perfusion model | Abstract similar documents |
N. A. Kaileva, A. A. Kulesh, N. Kh. Gorst, A. Yu. Bykova, V. E. Drobakha, K. V. Sobyanin, I. N. Shardakov, V. V. Shestakov | ||
"... NIHSS value (r = 0.55; p < 0.001), the size of a focus (r = 0.42; p < 0.001), FA in the contralateral ..." | ||
Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
"... .05-0.001). There were statistically significant differences in the measures of short-term (5.9±0 ..." | ||
Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
"... analyzer. The most marked significant (p<0.01) deviations in the values of visual evoked potentials (VEPs ..." | ||
Vol 7, No 1 (2015) | Vascular cognitive impairments in chronic kidney disease | Abstract similar documents |
I. V. Rogova, V. V. Fomin, I. V. Damulin, E. G. Minakova, O. Yu. Selivanova, Yu. A. Petleva | ||
"... –IV than in those with Stages I–II, as shown by the scores of the mini-mental state examination (p<0.001 ..." | ||
Vol 13, No 3 (2021) | Sleep disorder trends in 1988–2018 among the 25–64 years old population in Russia/Siberia (WHO MONICA Psychosocial study) | Abstract PDF (Eng) similar documents |
V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelgorn, A. V. Gafarova | ||
"... (χ2 =122.061; υ=16; p<0.001 – men; χ2 =230.626; υ=16; p<0.001 – women). In 1988–2018 there was a 2 ..." | ||
Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
"... from 19.8 to 23.3 points (p≥0.001) was observed in the omberacetam group. In other groups, an increase ..." | ||
Vol 14, No 3 (2022) | Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia | Abstract similar documents |
T. I. Nasonova, E. V. Parfenova | ||
"... ; p<0.001), sleepiness according to ESS (8.2±4.6 and 6.2±4.6 points; p=0.014), somatization according ..." | ||
Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
I. V. Miliukhina | ||
"... and anxiety (p < 0.001). Vortioxetine demonstrated an optimal balance between tolerability and clinical ..." | ||
Vol 13, No 2 (2021) | Depression, anxiety and motivation in arterial hypertension | Abstract similar documents |
S. K. Mezhmidinova, V. V. Zakharov, N. V. Vakhnina | ||
"... were significantly higher (p<0.01) in patients with hypertension-mediated organ damage or associated ..." | ||
Vol 11, No 1 (2019) | Social support and stroke risk: an epidemiological study of a population aged 25–64 years in Russia/Siberia (the WHO MONICA-psychosocial program) | Abstract PDF (Eng) similar documents |
A. V. Gafarova, E. A. Gromova, D. О. Panov, I. V. Gagulin, E. A. Krymov, V. V. Gafarov | ||
"... (95% CI, 1.5–8.7; p<0.01). Over the same follow-up period, the risk of stroke in the patients having ..." | ||
Online-first | Association of carriers of single nucleotide polymorphisms rs1143634 and rs16944 in gene Il-1B and rs6265 in gene BDNF with temporal lobe epilepsy | Abstract similar documents |
Y. S. Panina, D. V. Dmitrenko, N. A. Shnayder, E. V. Egorova, A. A. Usoltseva | ||
"... % CI: 1.31-3.08; p = 0.001) and the homozygous genotype CC (OR = 2.48; 95% CI: 1.47-4.17; p = 0.001 ..." | ||
1 - 70 of 118 Items | 1 2 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)